Medical Disclaimer

1. General Educational Guidance

All information, text, scientific summaries, research references, graphics, and materials displayed on Maxen USA (beamaxen.com) are provided strictly for general informational and educational purposes. Content on this site is not intended as medical advice, clinical recommendation, or a substitute for professional healthcare consultation.

Never disregard professional medical guidance, delay seeking clinical advice, or discontinue existing medications because of information you have read on this website.

2. Individual Product Warnings

MAXEN dietary supplements are formulated exclusively for healthy adults aged 18 years and older. Before beginning any new dietary supplement regimen:

• Consult with a licensed physician, particularly if you have a pre-existing medical condition, an acute or chronic diagnosis, or a family history of cardiovascular disorders.
• Adhere strictly to the suggested usage instructions printed on the product label. Do not exceed the recommended daily serving.
• Keep all product tins, capsules, and containers securely closed and out of reach of children and domestic animals.

3. Known Contraindications

MAXEN products should NOT be consumed by individuals who:

• Are pregnant, nursing, lactating, or actively planning a pregnancy.
• Are under 18 years of age.
• Have pre-existing hypotension (clinically low blood pressure) without explicit clearance from a cardiologist or primary care physician.
• Have severe renal (kidney) or hepatic (liver) impairment.
• Have known hypersensitivity or allergy to any active botanical or inactive excipient listed on the Supplement Facts panel.

4. Prescription Medication & Clinical Interactions

Due to the nitric oxide pathway and vasodilatory properties of L-Citrulline Malate, special clinical caution is required for individuals taking prescription pharmaceuticals:

• Nitrate Medications: Do not combine MAXEN Ignite with prescription nitrates (e.g., nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) as synergistic vasodilation may lead to dangerous drops in blood pressure.
• PDE5 Inhibitors: Consult your prescribing physician before concurrent use with phosphodiesterase type 5 inhibitors (e.g., sildenafil, tadalafil, vardenafil).
• Blood Pressure Medications: Individuals on ACE inhibitors, ARBs, beta-blockers, or calcium channel blockers must consult their healthcare provider prior to supplementation.
• Anticoagulants / Antiplatelets: Consult your physician if taking blood-thinning therapies.

5. Stop-Use Protocol

Discontinue use immediately and contact emergency medical services or your physician if you experience any unexpected adverse effects, including but not limited to:

• Severe dizziness, lightheadedness, or sudden faintness.
• Rapid heartbeat, palpitations, or chest tightness.
• Shortness of breath, facial swelling, or skin rashes.
• Severe gastrointestinal discomfort or nausea.

6. Adverse Event Reporting

In accordance with the Dietary Supplement and Nonprescription Drug Consumer Protection Act, consumers and healthcare providers may submit reports of serious adverse events directly to MAXEN:

7. Dietary & Allergen Information

MAXEN Ignite is manufactured in a cGMP-compliant facility. Formulations are stimulant-free and crafted without proprietary blends. For specific batch verification, lot testing, or ingredient verification, contact our concierge desk at Admin@beamaxen.com.